protectin-d1 and Respiratory-Syncytial-Virus-Infections

protectin-d1 has been researched along with Respiratory-Syncytial-Virus-Infections* in 1 studies

Other Studies

1 other study(ies) available for protectin-d1 and Respiratory-Syncytial-Virus-Infections

ArticleYear
Protectins PCTR1 and PD1 Reduce Viral Load and Lung Inflammation During Respiratory Syncytial Virus Infection in Mice.
    Frontiers in immunology, 2021, Volume: 12

    Viral pneumonias are a major cause of morbidity and mortality, owing in part to dysregulated excessive lung inflammation, and therapies to modulate host responses to viral lung injury are urgently needed. Protectin conjugates in tissue regeneration 1 (PCTR1) and protectin D1 (PD1) are specialized pro-resolving mediators (SPMs) whose roles in viral pneumonia are of interest. In a mouse model of Respiratory Syncytial Virus (RSV) pneumonia, intranasal PCTR1 and PD1 each decreased RSV genomic viral load in lung tissue when given after RSV infection. Concurrent with enhanced viral clearance, PCTR1 administration post-infection, decreased eosinophils, neutrophils, and NK cells, including NKG2D

    Topics: Administration, Intranasal; Animals; Docosahexaenoic Acids; Inflammation; Lung; Male; Mice; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Viral Load

2021